Value, Access and Regulatory Strategy Workshop

All stakeholders, including leaders across industry and health authorities, agree that finding answers to market access is critical to delivering breakthrough medicines to patients. Unfortunately, policies and practices do not always marry up.

This meeting will bring together professionals working with regulatory and value strategies. HTA bodies and regulators are breaking down silos, facilitating access to new promising medicines and increasing efficiencies in assessment processes. Similarly, R&D processes need to adapt to generate the appropriate evidence for registration and reimbursement that should allow patients’ timely access to innovative and promising drugs.

Bringing together policy makers, developers, and the patients as end users, to keep you ahead of the game with practical solutions.

Tagret Audience for the meeting:

Professionals working in regulatory affairs and HTA/market access
Professionals involved in drug development, e.g. clinicians, epidemiologists and biostatisticians
Patient organisations
Biotech companies, drug developers including SMEs
Decision makers (Ministries of Health etc.)

Exhibiting Opportunity

At this years’ Value Access & Regulatory Strategy Workshop, we are offering Tabletop Display for EUR 3000.00. A Tabletop display includes:

A 80cm x120cm table & a chair.

One basic electrical outlet.

A complimentary full meeting registration.

Additional Hosting Opportunities

Please download our prospectus for an exhibitor application form and all available hosting opportunities.

Download Prospectus

Exhibiting Companies

Evidera

Have an account?

Value, Access and Regulatory Strategy Workshop

Exhibiting Companies

Be informed and stay engaged.